BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21241354)

  • 1. Direct thrombin inhibitors.
    Lee CJ; Ansell JE
    Br J Clin Pharmacol; 2011 Oct; 72(4):581-92. PubMed ID: 21241354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Direct inhibitors of thrombin, hirudin, bivalirudin, and dabigatran etexilate].
    Meddahi S; Samama MM
    J Mal Vasc; 2011 Feb; 36(1):24-32. PubMed ID: 21239127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
    Streif W; Ageno W
    Wien Med Wochenschr; 2011 Feb; 161(3-4):73-9. PubMed ID: 21404143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dabigatran etexilate: an oral direct thrombin inhibitor for prophylaxis and treatment of thromboembolic diseases.
    Baetz BE; Spinler SA
    Pharmacotherapy; 2008 Nov; 28(11):1354-73. PubMed ID: 18956996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New anticoagulants - direct thrombin inhibitors].
    Brand B; Graf L
    Ther Umsch; 2012 Nov; 69(11):643-9. PubMed ID: 23117667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New anticoagulant agents: direct thrombin inhibitors.
    Nutescu EA; Shapiro NL; Chevalier A
    Cardiol Clin; 2008 May; 26(2):169-87, v-vi. PubMed ID: 18406993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in parenteral anticoagulation for arterial and venous thromboembolism.
    van Es N; Bleker SM; Büller HR; Coppens M
    Best Pract Res Clin Haematol; 2013 Jun; 26(2):203-13. PubMed ID: 23953908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct thrombin inhibitors fail to reverse the negative effects of heparin on lung growth and function after murine left pneumonectomy.
    Tsikis ST; Hirsch TI; Klouda T; Fligor SC; Pan A; Joiner MM; Wang SZ; Quigley M; Devietro A; Mitchell PD; Kishikawa H; Yuan K; Puder M
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L213-L225. PubMed ID: 38113296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors.
    Lepor NE
    Rev Cardiovasc Med; 2007; 8 Suppl 3():S9-17. PubMed ID: 17917621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dabigatran etexilate: A novel oral direct thrombin inhibitor.
    Blommel ML; Blommel AL
    Am J Health Syst Pharm; 2011 Aug; 68(16):1506-19. PubMed ID: 21817082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argatroban, bivalirudin, and lepirudin do not decrease clot propagation and strength as effectively as heparin-activated antithrombin in vitro.
    Nielsen VG; Steenwyk BL; Gurley WQ; Pereira SJ; Lell WA; Kirklin JK
    J Heart Lung Transplant; 2006 Jun; 25(6):653-63. PubMed ID: 16730571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement.
    Salazar CA; Malaga G; Malasquez G
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD005981. PubMed ID: 20393944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the aPTT with alternative tests for monitoring direct thrombin inhibitors in patient samples.
    Lind SE; Boyle ME; Fisher S; Ishimoto J; Trujillo TC; Kiser TH
    Am J Clin Pathol; 2014 May; 141(5):665-74. PubMed ID: 24713737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin.
    Coughlin MA; Bartlett RH
    ASAIO J; 2015; 61(6):652-5. PubMed ID: 26309096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational success stories: development of direct thrombin inhibitors.
    Coppens M; Eikelboom JW; Gustafsson D; Weitz JI; Hirsh J
    Circ Res; 2012 Sep; 111(7):920-9. PubMed ID: 22982873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hitting back HIT.
    Gude D
    Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing.
    Gosselin RC; King JH; Janatpur KA; Dager WH; Larkin EC; Owings JT
    Arch Pathol Lab Med; 2004 Oct; 128(10):1142-5. PubMed ID: 15387708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical use of a new class of anticoagulant drugs: the direct thrombin inhibitors].
    Puccio D; Montalto S; Valerio MC; Ventimiglia A; Caronia A; Novo S
    G Ital Cardiol (Rome); 2006 Nov; 7(11):739-46. PubMed ID: 17216915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.